Spectrum Pharma (SPPI) Tops Q2 EPS by 21c

August 6, 2015 5:28 PM EDT

Spectrum Pharma (NASDAQ: SPPI) reported Q2 EPS of ($0.01), $0.21 better than the analyst estimate of ($0.22). Revenue for the quarter came in at $44.98 million versus the consensus estimate of $34.48 million.

For earnings history and earnings-related data on Spectrum Pharma (SPPI) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings